评估新型拭子和病毒运输培养基用于SARS-CoV-2检测的方法
本文针对COVID-19大流行期间采样装置短缺问题,提出了一套系统评估未注册制造商拭子和病毒运输培养基(VTM)适用性的方法。评估内容包括装置完整性检查、拭子和VTM的无菌性及体外性能、VTM稳定性以及临床性能,并在一线微生物实验室中应用该方法评估某未注册制造商的产品,结果不理想而未能采用。
要点
- 实验室需系统评估未注册采集装置,包括完整性、无菌性、性能及稳定性。
- 评估应涵盖拭子和VTM的体外性能与临床性能。
- 某未注册制造商产品评估结果不理想,提示需严格验证。
核心结论
- 诊断实验室应采用系统、稳健的方法评估替代的未注册拭子和VTM,以确保检测供应链。
研究设计与样本
- 本文为方法学论述,提出评估未注册采集装置的框架,并在一线医学微生物实验室对某未注册制造商的拭子和VTM进行了应用评估。
主要发现
- 对某未注册制造商拭子和VTM的评估结果不理想,因此未予实施。
关键数值与推荐
- 评估标准包括装置完整性检查、拭子和VTM的无菌性与体外性能、VTM稳定性以及临床性能检查。
临床怎么用
- 实验室在采用替代采集装置前应进行系统验证,确保其适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In light of the present pandemic of novel coronavirus disease 2019 (COVID-19) and the unprecedented high demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing worldwide, there are shortages of established specimen collection devices for respiratory viral testing for diagnostic microbiology laboratories. This creates the need to validate unverified collection devices from manufacturers that may not be a registered supplier for medical devices. As clinical laboratories do not routinely perform quality control of established collection devices, there is a need to have a systematic, robust approach to the assessment of substitute unregistered collection swabs and viral transport media (VTM). A discussion of the aspects requiring consideration when determining the suitability and implementation of new collection devices is presented. These specific assessment criteria include an inspection of device integrity, determination of swab and VTM sterility and in vitro performance, VTM stability, and examination of the clinical performance of the device. This method was used in a front-line medical microbiology laboratory on swabs and VTM from an unregistered manufacturer, with suboptimal results that precluded implementation. As the pandemic continues, it will be important for diagnostic laboratories to adopt a flexible and streamlined approach to maintaining adequate supply chains for testing reagents and materials.
引用
- Locher K, Velapatino B, Caza M, et al. Approach to Assessment of New Swabs and Viral Transport Media for SARS-CoV-2 Testing. J Clin Microbiol. 2021. PMID: 33139423. doi:10.1128/JCM.01562-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。